ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,461Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 823

$1.2M Total Retail Price of All Prescriptions

Rank: 19 out of 823

630 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 630 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 8,542 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$97 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
NEXIUM 335 231 1 10
LEVOTHYROXINE SODIUM 328 234 2 6
METFORMIN HCL 323 219 3 14
HYDROCODONE-ACETAMINOPHEN 286 112 S3 4 1
SIMVASTATIN 284 203 5 2
LEVOFLOXACIN 284 192 5 101
LISINOPRIL 277 194 7 4
TRAMADOL HCL 244 175 8 15
ALENDRONATE SODIUM 239 214 9 42
METOPROLOL TARTRATE 235 171 10 11
CRESTOR 220 151 11 20
FLUOXETINE HCL 216 107 12 84
FUROSEMIDE 189 140 13 7
AMLODIPINE BESYLATE 184 149 14 3
OMEPRAZOLE 184 110 14 5
NAMENDA 169 166 16 28
LYRICA 156 84 17 58
JANUVIA 149 79 18 70
ZOLPIDEM TARTRATE 142 101 19 17
GLIPIZIDE 134 90 20 105
HYDROCHLOROTHIAZIDE 132 94 21 29
METOPROLOL SUCCINATE 130 101 22 9
SERTRALINE HCL 120 94 23 38
PREDNISONE 116 82 24 31
METOCLOPRAMIDE HCL 114 77 25 95
TAMSULOSIN HCL 109 82 26 21
ESCITALOPRAM OXALATE 109 86 26 99
TRICOR 105 75 28 150
CLOPIDOGREL 102 78 29 16
AZITHROMYCIN 93 59 30 48
CYCLOBENZAPRINE HCL 93 38 R 30 63
INSULIN SYRINGE 92 55 32 125
PEN NEEDLE 91 50 33 96
ATENOLOL 90 73 34 47
ISOSORBIDE MONONITRATE ER 89 73 35 49
GABAPENTIN 87 40 36 8
LOSARTAN POTASSIUM 84 57 37 26
WARFARIN SODIUM 84 65 37 18
NOVOLOG MIX 70-30 83 50 39 214
ATORVASTATIN CALCIUM 82 69 40 13
MECLIZINE HCL 81 63 41 184
DICLOFENAC SODIUM 80 65 42 174
PLAVIX 78 62 43 25
MELOXICAM 75 59 44 27
NOVOLOG MIX 70-30 FLEXPEN 74 27 45 222
HYDRALAZINE HCL 72 43 46 109
DONEPEZIL HCL 71 67 47 24
ONGLYZA 70 39 48 275
BUSPIRONE HCL 70 42 48 170
NOVOLIN R 68 51 50 296
CYMBALTA 68 15 50 40
CARBIDOPA-LEVODOPA 67 58 52 44
DIOVAN HCT 67 44 52 79
LEVEMIR 66 52 54 270
JANUMET 65 38 55 193
BYSTOLIC 64 46 56 98
POTASSIUM CHLORIDE 63 60 57 22
GEMFIBROZIL 61 33 58 235
DIOVAN 60 54 59 35
BENICAR HCT 58 55 60 195
LANTUS 58 25 60 76
GLYBURIDE-METFORMIN HCL 58 30 R 60 121
VESICARE 57 36 63 126
CLINDAMYCIN HCL 57 28 63 297
DIGOXIN 55 51 65 33
AMOX TR-POTASSIUM CLAVULANATE 54 25 66 238
EXELON 54 54 66 102
QUETIAPINE FUMARATE 52 19 68 73
GLYBURIDE 52 42 R 68 150
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 30 70 91
CIPROFLOXACIN HCL 51 42 70 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.